Erbitux Approved As Monotherapy In Metastatic Colorectal Cancer Setting
This article was originally published in The Pink Sheet Daily
Executive Summary
Labeling for ImClone/Bristol’s epidermal growth factor receptor inhibitor is updated to include survival data as a single agent in colorectal cancer setting.